Hubatsch I - Search Results

1

Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain.

Johansson A, Hubatsch I, Akerblom E, Lindeberg G, Winiwarter S, Danielson UH, Hallberg A. Johansson A, et al. Among authors: hubatsch i. Bioorg Med Chem Lett. 2001 Jan 22;11(2):203-6. doi: 10.1016/s0960-894x(00)00625-9. Bioorg Med Chem Lett. 2001. PMID: 11206459

2

Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of Hepatitis C virus.

Poliakov A, Hubatsch I, Shuman CF, Stenberg G, Danielson UH. Poliakov A, et al. Among authors: hubatsch i. Protein Expr Purif. 2002 Aug;25(3):363-71. doi: 10.1016/s1046-5928(02)00042-6. Protein Expr Purif. 2002. PMID: 12182815

3

In vitro ADMET and physicochemical investigations of poly-N-methylated peptides designed to inhibit Abeta aggregation.

Bose PP, Chatterjee U, Hubatsch I, Artursson P, Govender T, Kruger HG, Bergh M, Johansson J, Arvidsson PI. Bose PP, et al. Among authors: hubatsch i. Bioorg Med Chem. 2010 Aug 15;18(16):5896-902. doi: 10.1016/j.bmc.2010.06.087. Epub 2010 Jul 1. Bioorg Med Chem. 2010. PMID: 20659803

4

Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.

Hubatsch I, Arvidsson PI, Seebach D, Luthman K, Artursson P. Hubatsch I, et al. J Med Chem. 2007 Oct 18;50(21):5238-42. doi: 10.1021/jm070148u. Epub 2007 Sep 21. J Med Chem. 2007. PMID: 17887660

5

Poorly soluble marketed drugs display solvation limited solubility.

Bergström CA, Wassvik CM, Johansson K, Hubatsch I. Bergström CA, et al. Among authors: hubatsch i. J Med Chem. 2007 Nov 15;50(23):5858-62. doi: 10.1021/jm0706416. Epub 2007 Oct 11. J Med Chem. 2007. PMID: 17929794

6

Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium.

Hubatsch I, Lazorova L, Vahlne A, Artursson P. Hubatsch I, et al. Antimicrob Agents Chemother. 2005 Mar;49(3):1087-92. doi: 10.1128/AAC.49.3.1087-1092.2005. Antimicrob Agents Chemother. 2005. PMID: 15728907 Free PMC article.

7

Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers.

Hubatsch I, Ragnarsson EG, Artursson P. Hubatsch I, et al. Nat Protoc. 2007;2(9):2111-9. doi: 10.1038/nprot.2007.303. Nat Protoc. 2007. PMID: 17853866

8

Structural features determining the intestinal epithelial permeability and efflux of novel HIV-1 protease inhibitors.

Lazorova L, Hubatsch I, Ekegren JK, Gising J, Nakai D, Zaki NM, Bergström CA, Norinder U, Larhed M, Artursson P. Lazorova L, et al. Among authors: hubatsch i. J Pharm Sci. 2011 Sep;100(9):3763-72. doi: 10.1002/jps.22570. Epub 2011 Apr 13. J Pharm Sci. 2011. PMID: 21491458 Free PMC article.

9

The cyclopentenone product of lipid peroxidation, 15-A(2t)-isoprostane (8-isoprostaglandin A(2)), is efficiently conjugated with glutathione by human and rat glutathione transferase A4-4.

Hubatsch I, Mannervik B, Gao L, Roberts LJ, Chen Y, Morrow JD. Hubatsch I, et al. Chem Res Toxicol. 2002 Sep;15(9):1114-8. doi: 10.1021/tx020027r. Chem Res Toxicol. 2002. PMID: 12230403

10

Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation.

Hubatsch I, Ridderström M, Mannervik B. Hubatsch I, et al. Biochem J. 1998 Feb 15;330 ( Pt 1)(Pt 1):175-9. doi: 10.1042/bj3300175. Biochem J. 1998. PMID: 9461507 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters